Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone
Clinical trial NCT04133012 · COMPLETED
Trial details
- NCT number
- NCT04133012
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2023-06-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.